Filters

Minori Miyake-Kashima, Yoji Takano, Mari Tanaka, Yoshiyuki Satake, Tetsuya Kawakita, Murat Dogru, Naoko Asano-Kato, Kazumi Fukagawa, Hiroshi Fujishima

Japanese journal of ophthalmology 2005;48(6):587-90

Full Text

Abstract

Incidence of cystoid macular edema following routine cataract surgery using NSAIDs alone or with corticosteroids.

Chris Komanski, Kevin Chen, Roland Y Lee, Keith A Walter

Arquivos brasileiros de oftalmologia 2020;83(1):55-61

Free Full Text

Abstract

Topical 0.1% Bromfenac Sodium for Intraoperative Miosis Prevention and Prostaglandin E Inhibition in Femtosecond Laser-Assisted Cataract Surgery.

Weirong Chen, Jing Li, Wu Xiang, Bo Zhang, Wan Chen, Haotian Lin, Hui Chen

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2017;33(3):193-201

Full Text

Abstract

The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.

Ji Won Jung, Byung Hoon Chung, Eung Kweon Kim, Kyoung Yul Seo, Tae-im Kim

Yonsei medical journal 2016;56(6):1671-7

Free Full Text

Abstract

COMPARISON OF THE EFFECTS OF EIGHT DIFFERENT TOPICAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ON REDUCING INTRAVITREAL INJECTION-INDUCED PAIN.

Hande Güçlü, Rüveyde Garİp, Sultan Kaya, Ahmet Kürşad SakallioĞlu

Retina (Philadelphia, Pa.) 2024;44(7):1196-1202

Full Text

Abstract

Results: 1 – 15 / 30

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Bromobenzenes""[mesh_terms]

A case of sodium bromfenac eye drop-induced toxic epidermal necrolysis and literature review.

Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Retinal Diseases.

Topical bromfenac reduces multiple inflammatory cytokines in the aqueous humour of pseudophakic patients.

Ocular pharmacokinetics of a single dose of bromfenac sodium ophthalmic solution 0.1% in human aqueous humor.

Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.

Topical NSAIDs effect on corneal sensitivity.

Topical NSAIDs impact on macular oedema and visual outcome after phacoemulsification: systematic review of RCTs with network meta-analysis.

Efficacy and safety of sodium bromfenac eye drops in the treatment of postoperative inflammation in cataract surgery: A protocol for systematic review and meta-analysis.

A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.

Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.

Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis.

Incidence of cystoid macular edema following routine cataract surgery using NSAIDs alone or with corticosteroids.

Topical 0.1% Bromfenac Sodium for Intraoperative Miosis Prevention and Prostaglandin E Inhibition in Femtosecond Laser-Assisted Cataract Surgery.

The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.

COMPARISON OF THE EFFECTS OF EIGHT DIFFERENT TOPICAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ON REDUCING INTRAVITREAL INJECTION-INDUCED PAIN.

Results for
""Bromobenzenes""[mesh_terms]